These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23606272)

  • 1. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.
    Boer MC; van Meijgaarden KE; Bastid J; Ottenhoff TH; Joosten SA
    Eur J Immunol; 2013 Jul; 43(7):1925-32. PubMed ID: 23606272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion.
    Herrath J; Chemin K; Albrecht I; Catrina AI; Malmström V
    Eur J Immunol; 2014 Oct; 44(10):2979-89. PubMed ID: 24990235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells.
    Noble A; Mehta H; Lovell A; Papaioannou E; Fairbanks L
    Eur J Immunol; 2016 Jun; 46(6):1438-48. PubMed ID: 26990545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells.
    Boer MC; van Meijgaarden KE; Joosten SA; Ottenhoff TH
    PLoS One; 2014; 9(4):e94192. PubMed ID: 24714620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
    Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
    Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
    Åkesson K; Tompa A; Rydén A; Faresjö M
    Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished levels of regulatory T cell subsets (CD8+Foxp3, CD4+Foxp3 and CD4+CD39+Foxp3) but increased Foxp3 expression in adipose tissue from overweight subjects.
    Núñez Ruiz A; Cortés-Garcia JD; Cortez-Espinosa N; Herrera-Rojas PI; Ruíz-Rodríguez VM; Salgado-Bustamante M; García-Hernández MH; Reynaga-Hernández E; Martínez-Jimenez Vdel C; Portales-Pérez DP
    Nutrition; 2016 Sep; 32(9):943-54. PubMed ID: 27160497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
    Parodi A; Battaglia F; Kalli F; Ferrera F; Conteduca G; Tardito S; Stringara S; Ivaldi F; Negrini S; Borgonovo G; Simonato A; Traverso P; Carmignani G; Fenoglio D; Filaci G
    Cancer Immunol Immunother; 2013 May; 62(5):851-62. PubMed ID: 23359087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells.
    Gouttefangeas C; Mansur I; Schmid M; Dastot H; Gélin C; Mahouy G; Boumsell L; Bensussan A
    Eur J Immunol; 1992 Oct; 22(10):2681-5. PubMed ID: 1396972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.
    Raczkowski F; Rissiek A; Ricklefs I; Heiss K; Schumacher V; Wundenberg K; Haag F; Koch-Nolte F; Tolosa E; Mittrücker HW
    PLoS One; 2018; 13(5):e0197151. PubMed ID: 29742141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.
    Schuler PJ; Harasymczuk M; Schilling B; Lang S; Whiteside TL
    J Immunol Methods; 2011 Jun; 369(1-2):59-68. PubMed ID: 21513715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
    Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
    J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
    Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
    PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability.
    Lu Y; Wang X; Gu J; Lu H; Zhang F; Li X; Qian X; Wang X; Lu L
    Int Immunopharmacol; 2015 Oct; 28(2):925-30. PubMed ID: 25864618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.